Job title: Scientist l, Manager, Analytical Development
Messer is the manager of Preclinical and Clinical Analytical Development at AGTC, Alachua, Florida where he designs, develops, and qualifies AAV preclinical and clinical assays, including cell-based and potency assays, for multiple clinical ophthalmic, otological, and neuronal gene therapies resulting in support of IND enabling first-in-human orphan drugs. He holds M.S. and Ph.D. degrees in biomedical science from the University of Florida College of Medicine. His doctoral work encompassed biochemistry of AAV capsids as well as characterization of novel epigenetic anti-HSV-1 drugs to prevent or treat latent neuronal infections. He is a former Scientific Director of the Monoclonal Antibody Core group at the Interdisciplinary Center for Biotechnology Research at the University of Florida. He was formerly awarded travel grant awards for the American Society of Gene & Cell Therapy (2011), Symposium Scholarships for the International Herpes Virus Workshop (2013, 2014), and the NIH/NIAID Chromatin Control of Viral Infection (2014).
Overview of Challenges in rAAV Custom Assay Design 8:30 am
Understanding approaches such as rational design for improved risk assessment on key project systems in ADA Recognizing sources of inherent variability in potency assay development for cell & gene therapy products Assimilating exploratory and bio-pharmaceutics development in potency assay work with complex MOARead more
day: Day Two